QUALAQUIN Drug Patent Profile
✉ Email this page to a colleague
When do Qualaquin patents expire, and what generic alternatives are available?
Qualaquin is a drug marketed by Sun Pharm Industries and is included in one NDA.
The generic ingredient in QUALAQUIN is quinine sulfate. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Qualaquin
A generic version of QUALAQUIN was approved as quinine sulfate by TEVA PHARMS on September 28th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QUALAQUIN?
- What are the global sales for QUALAQUIN?
- What is Average Wholesale Price for QUALAQUIN?
Summary for QUALAQUIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 97 |
Clinical Trials: | 3 |
Patent Applications: | 2,769 |
Drug Prices: | Drug price information for QUALAQUIN |
What excipients (inactive ingredients) are in QUALAQUIN? | QUALAQUIN excipients list |
DailyMed Link: | QUALAQUIN at DailyMed |
Recent Clinical Trials for QUALAQUIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mutual Pharmaceutical Company, Inc. | Phase 1 |
Pharmacology for QUALAQUIN
Drug Class | Antimalarial |
US Patents and Regulatory Information for QUALAQUIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Industries | QUALAQUIN | quinine sulfate | CAPSULE;ORAL | 021799-001 | Aug 12, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |